When Ginkgo Bioworks’ head of codebase Dr Patrick Boyle was working on his doctoral research between 2006-12, he was “basically ordering DNA one gene at a time,” he recalls. “I think I ordered less ...

A multibillion-dollar SPAC deal? Check. An international acquisition? Check. An mRNA vaccine production "breakthrough?" Ginkgo Bioworks says it has that, too. With its latest manufacturing update, ...

Nine Brown and RISD students had the unique opportunity Thursday to tour the laboratory of Ginkgo Bioworks, a major biotechnology company, to learn more about the new field of biological design. The ...

NEW YORK - Thanks to recent advances in synthetic biology - a hybrid discipline of engineering and biology that makes possible the manipulation of DNA of microorganisms such as yeast, bacteria, fungi ...